Millennium Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
53,877
+9,042
+20% +$237K 0.71% 30
2026
Q1
$1.26M Buy
44,835
+1,148
+3% +$30.6K 0.77% 30
2025
Q4
$1.09M Sell
43,687
-568
-1% -$14.3K 0.64% 32
2025
Q3
$1.13M Sell
44,255
-1,301
-3% -$32.1K 0.68% 30
2025
Q2
$1.1M Sell
45,556
-6,241
-12% -$146K 0.74% 31
2025
Q1
$1.31M Buy
51,797
+2
+0% +$52 0.97% 28
2024
Q4
$1.37M Buy
51,795
+11,517
+29% +$312K 0.94% 28
2024
Q3
$1.17M Sell
40,278
-2,731
-6% -$79.7K 0.76% 32
2024
Q2
$1.2M Sell
43,009
-2,242
-5% -$61.7K 0.8% 33
2024
Q1
$1.26M Sell
45,251
-1,887
-4% -$52.4K 0.89% 33
2023
Q4
$1.36M Sell
47,138
-822
-2% -$24.8K 1.04% 26
2023
Q3
$1.59M Sell
47,960
-1,032
-2% -$36.5K 1.36% 18
2023
Q2
$1.8M Buy
48,992
+1,806
+4% +$70.3K 1.48% 16
2023
Q1
$1.93M Buy
47,186
+1,473
+3% +$63.6K 1.72% 13
2022
Q4
$2.34M Sell
45,713
-935
-2% -$44.8K 2.37% 11
2022
Q3
$2.04M Sell
46,648
-863
-2% -$41.9K 2.15% 11
2022
Q2
$2.49M Buy
47,511
+1,391
+3% +$70.9K 2.43% 11
2022
Q1
$2.39M Buy
46,120
+310
+0.7% +$16.1K 1.93% 14
2021
Q4
$2.71M Buy
+45,810
New +$2.27M 2.11% 13

Other funds holding PFE

Millennium Capital Advisors's PFE Position: Q2 2026 in Review

Millennium Capital Advisors increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $237K and bringing the position to 53,877 shares worth $1.3M. The position accounts for 0.71% of the portfolio, ranked #30.

Millennium Capital Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.71M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Millennium Capital Advisors held 53,877 shares of Pfizer worth $1.3M as of Q2 2026.
  • Millennium Capital Advisors bought 9,042 Pfizer shares in Q2 2026, an estimated $237K.
  • Pfizer made up 0.71% of Millennium Capital Advisors's portfolio in Q2 2026, its #30 holding.
  • Millennium Capital Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Millennium Capital Advisors's Pfizer position peaked at $2.71M in Q4 2021.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Millennium Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.